Specimen Collection: Clinical Trials

339 trials of Specimen Collection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

166 recruiting, 83 active not recruiting, 23 not yet recruiting, 20 terminated. 339 Phase 1, 89 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1339Recruiting 166, Active not recruiting 83, Not yet recruiting 23, Terminated 20, Withdrawn 20, Suspended 18, Completed 8, Unknown 1
Phase 289Recruiting 48, Active not recruiting 27, Not yet recruiting 5, Suspended 3, Terminated 3, Withdrawn 2, Completed 1

Follow Specimen Collection: new trials by email Literature Review of Specimen Collection trials Research Report on Specimen Collection

Trials (filtered) newest first · largest first

All 339 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Asciminib-Based Induction Therapy for the Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Asciminib, Biospecimen Collection, Blinatumomab - B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 1Not yet recruitingCity of Hope Medical Center212027-10-132026-11-03
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Biospecimen Collection, Computed Tomography, Futibatinib - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8
Phase 1Not yet recruitingNorthwestern University182027-09-092026-10-20
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1RecruitingNational Cancer Institute (NCI)152027-07-052026-11-05
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
Biospecimen Collection, Diagnostic Imaging Testing, Echocardiography Test - Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)312027-06-012026-10-22
Lenalidomide and Cosibelimab for the Treatment of Relapsed/Refractory Mycosis Fungoides or Sézary Syndrome
Biospecimen Collection, Computed Tomography, Cosibelimab - Recurrent Mycosis Fungoides, Recurrent Sezary Syndrome
Phase 1Not yet recruitingCity of Hope Medical Center142027-05-162026-11-09
A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat
Archive Sample Retrieval, Biospecimen Collection, pH Low Insertion Peptide-exatecan Conjugate CBX-12 - Recurrent Childhood Ewing Sarcoma, Recurrent Childhood Malignant Solid Neoplasm
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group792027-05-072026-09-22
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 1Not yet recruitingCity of Hope Medical Center362027-05-062026-09-25
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1RecruitingCity of Hope Medical Center162027-04-172026-11-13
Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)1622027-04-122026-10-16
Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Childhood Malignant Solid Neoplasm, Recurrent Childhood Neuroblastoma
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group772027-04-092026-09-15
Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
Biospecimen Collection, Computed Tomography, Positron Emission Tomography - Recurrent Plasmablastic Lymphoma, Refractory Plasmablastic Lymphoma
Phase 1RecruitingNational Cancer Institute (NCI)302027-03-262026-10-20
FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma
Biospecimen Collection, Computed Tomography, Dexamethasone - Glioblastoma, Malignant Glioma
Phase 1Not yet recruitingCity of Hope Medical Center242027-02-172026-08-27
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Biospecimen Collection, Camonsertib, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingNational Cancer Institute (NCI)392027-02-132026-10-29
Cannabis Gummy for the Improvement of Sleep and Quality of Life in Patients With Cancer, Pillow Trial
Actigraphy, Best Practice, Biospecimen Collection - Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Phase 1 / Phase 2Not yet recruitingTheodore Brasky PhD502027-01-152026-10-14
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Burkitt Lymphoma, Double-Expressor Lymphoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)502027-01-112026-10-14
Evaluating the Effects of Propionate and Butyrate Supplementation on the Intestinal Health of Healthy Volunteers
Biospecimen Collection, Microencapsulated Sodium Butyrate, Microencapsulated Sodium Propionate - Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm
Phase 1Not yet recruitingCity of Hope Medical Center122027-01-042026-11-10
Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma
Azacitidine, Belinostat, Biospecimen Collection - Recurrent Anaplastic Large Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma
Phase 1RecruitingCity of Hope Medical Center402027-01-032026-10-30
IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate Cancer
FH-STEAP1 IL-18 CAR T cells, Antiandrogen Therapy, Biospecimen Collection - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 1Not yet recruitingFred Hutchinson Cancer Center202026-12-312026-11-12
Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma
Biospecimen Collection, Cisplatin, Computed Tomography - Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma
Phase 1Not yet recruitingNational Cancer Institute (NCI)162026-12-302026-11-06
Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy
Biospecimen Collection, Internet-Based Intervention, Medical Device Usage and Evaluation - Advanced Cutaneous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8
Phase 1Not yet recruitingCity of Hope Medical Center82026-12-232026-06-05

Showing 20 of 339. Sign in to see all of them.

Conditions studied

Leukemia, Myeloid, Acute (40)  ·  Neoplasm Metastasis (38)  ·  Colorectal Neoplasms (22)  ·  Lung Neoplasms (22)  ·  Myelodysplastic Syndromes (20)  ·  Pancreatic Neoplasms (18)  ·  Melanoma (17)  ·  Carcinoma, Non-Small-Cell Lung (16)  ·  Prostatic Neoplasms (15)  ·  Multiple Myeloma (14)  ·  Glioblastoma (13)  ·  Lymphoma, Large B-Cell, Diffuse (13)  ·  Triple Negative Breast Neoplasms (13)  ·  Breast Neoplasms (12)  ·  Carcinoma, Renal Cell (11)

Sponsors

National Cancer Institute (NCI) (131)  ·  City of Hope Medical Center (58)  ·  Mayo Clinic (37)  ·  Fred Hutchinson Cancer Center (13)  ·  Roswell Park Cancer Institute (11)  ·  OHSU Knight Cancer Institute (10)  ·  Children's Oncology Group (9)  ·  University of Michigan Rogel Cancer Center (8)  ·  Jonsson Comprehensive Cancer Center (7)  ·  Ohio State University Comprehensive Cancer Center (7)  ·  Northwestern University (6)  ·  University of Southern California (5)  ·  Emory University (3)  ·  Nathan Denlinger (2)  ·  Thomas Jefferson University (2)

Countries

United States (325)  ·  Canada (19)  ·  Puerto Rico (5)  ·  Australia (4)  ·  New Zealand (1)

Top investigators

Amandeep Salhotra (5)  ·  Ibrahim Aldoss (4)  ·  Jana L Portnow (3)  ·  Liza C Villaruz (3)  ·  Marwan G Fakih (3)  ·  Rosa Nadal Rios, MD, PhD (3)  ·  Ryotaro Nakamura (3)  ·  Stephen E Spurgeon (3)  ·  Tycel J Phillips (3)  ·  Alex Chehrazi-Raffle, MD (2)  ·  Amanda Blackmon (2)  ·  Anwaar Saeed (2)  ·  Behnam Badie (2)  ·  Catherine S Diefenbach (2)  ·  Christina Poh (2)

Results publications

PMID 35175355, PMID 23810467, PMID 25218906, PMID 31151904, PMID 31154457, PMID 32853585, PMID 32915679, PMID 33641042, PMID 33677480, PMID 34265312, PMID 35031545, PMID 35080914, PMID 35205614, PMID 35264434, PMID 35470301, PMID 35622074, PMID 36092362, PMID 36228112, PMID 36898933, PMID 36997799, PMID 37185961, PMID 37505794, PMID 37597578, PMID 37962072, PMID 38236249, PMID 38261444, PMID 38407630, PMID 38497709, PMID 38501690, PMID 38737792, PMID 38934093, PMID 38954785, PMID 39356983, PMID 39415930, PMID 39673591, PMID 39841295, PMID 39863139, PMID 39970230, PMID 40226119, PMID 40611889, PMID 40717483, PMID 40721981, PMID 40873341, PMID 41118283, PMID 41180818, PMID 41206673, PMID 41276366, PMID 41545594, PMID 41662628, PMID 41680482

NIH funding

P30CA033572 (59), UM1CA186689 (20), UM1CA186709 (18), UM1CA186690 (14), UM1CA186717 (13), UM1CA228823 (12), UM1CA186688 (10), UM1CA186712 (10), P30CA060553 (9), UM1CA186644 (9), UM1CA186691 (6), UM1CA186704 (6), P30CA014089 (5), U10CA180868 (5), P30CA014520 (4)